OWCP (OWC Pharmaceutical Research) Receivables Turnover: 0.00 (As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is OWC Pharmaceutical Research Receivables Turnover?

OWC Pharmaceutical Research OWCP Receivables Turnover is 0.00 as of Sep. 2019.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. OWC Pharmaceutical Research's Revenue for the three months ended in Sep. 2019 was $0.00 Mil. OWC Pharmaceutical Research's average Accounts Receivable for the three months ended in Sep. 2019 was $0.00 Mil.


OWC Pharmaceutical Research  (OTCPK:OWCP) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


OWC Pharmaceutical Research Receivables Turnover Related Terms


OWC Pharmaceutical Research Receivables Turnover Historical Data

* Premium members only.

The historical data trend for OWC Pharmaceutical Research's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OWC Pharmaceutical Research Receivables Turnover Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OWCP vs PARNF, CANB, CXUS: Receivables Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, OWC Pharmaceutical Research's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OWC Pharmaceutical Research Receivables Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OWC Pharmaceutical Research's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where OWC Pharmaceutical Research's Receivables Turnover falls into.



OWC Pharmaceutical Research Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

OWC Pharmaceutical Research's Receivables Turnover for the fiscal year that ended in Dec. 2018 is calculated as

Receivables Turnover (A: Dec. 2018 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2018 ) / ((Accounts Receivable (A: Dec. 2017 ) + Accounts Receivable (A: Dec. 2018 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

OWC Pharmaceutical Research's Receivables Turnover for the quarter that ended in Sep. 2019 is calculated as

Receivables Turnover (Q: Sep. 2019 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Sep. 2019 ) / ((Accounts Receivable (Q: Jun. 2019 ) + Accounts Receivable (Q: Sep. 2019 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
OWC Pharmaceutical Research (OWCP) has a Receivables Turnover of 0.00 as of Sep. 2019. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on OWC Pharmaceutical Research and its competitors.
Is OWC Pharmaceutical Research's Receivables Turnover too high?
OWC Pharmaceutical Research's current Receivables Turnover is 0.00.
How does OWC Pharmaceutical Research's Receivables Turnover compare to PARNF and CANB?
OWC Pharmaceutical Research's Receivables Turnover of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Receivables Turnover is 5.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 949 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on OWC Pharmaceutical Research and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OWC Pharmaceutical Research's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OWC Pharmaceutical Research stock overvalued right now?
OWC Pharmaceutical Research (OWCP) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For OWC Pharmaceutical Research (OWCP), the current Receivables Turnover is 0.00 as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OWC Pharmaceutical Research Business Description

Address 2 Ben Gurion Street, Ramat Gan, ISR, 4514760
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.